Open AccessThe Impact of Biologics for the Management of Inflammatory Bowel Disease on Liver Enzymes
Author(s) -
Aby Elizabeth S.,
Lake John R.,
Vaughn Byron P.
Publication year - 2020
Publication title -
clinical liver disease
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.421
H-Index - 14
ISSN - 2046-2484
DOI - 10.1002/cld.1005
Subject(s) - medicine , adalimumab , infliximab , golimumab , proinflammatory cytokine , natalizumab , vedolizumab , inflammatory bowel disease , certolizumab pegol , ustekinumab , liver injury , immunology , tumor necrosis factor alpha , pharmacology , disease , inflammation
Watch a video presentation of this article
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom